Buy Cadila Healthcare Ltd., target Rs 440.0 : Citigroup

Citigroup sees limited scope for further deterioration in Cadilla Healthcare financials.

Citigroup has Buy call on Cadila Healthcare Ltd. with a target price of Rs 440.0. The current market price of Cadila Healthcare Ltd. is 371.9. Time period given by analyst is year, when Cadila Healthcare Ltd. price can reach defined target. The pharma major is likely to file for site transfers of pipeline products over the next three months. Asacol HD authorised generic sales are likely to reflect from August 2016. India sales got impacted by National List of Essential Medicines (NLEM), FDC ban and uncertainty in trade. Citigroup sees limited scope for further deterioration in financials.
ADVERTISEMENT
READ MORE

READ MORE:

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › Markets › Stocks › Recos › Buy Cadila Healthcare Ltd., target Rs 440.0 : Citigroup
Text Size:AAA
Success
This article has been saved

*

+